Bruce C. Cozadd, Director at Jazz Pharmaceuticals plc (JAZZ), sold 6,000 shares at $235.12 ($1.4M) on 2026-06-01, disclosed to the SEC on 2026-06-03.
Scheduled sale ($1.4M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| JAZZ | SELL | 2026-07-06 | $1.4M | — | Filing → |
| JAZZ | SELL | 2026-05-05 | $1.2M | — | Filing → |
| JAZZ | SELL | 2026-04-03 | $1.1M | — | Filing → |